Company Filing History:
Years Active: 2024-2025
Title: Innovations of Geun Seon Ahn in Bioprinting Technology.
Introduction
Geun Seon Ahn is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of bioprinting, particularly in the development of systems that enhance the efficiency and effectiveness of bioink supply during 3D printing processes. With a total of 2 patents, Ahn's work is paving the way for advancements in tissue engineering and regenerative medicine.
Latest Patents
Ahn's latest patents include a bio-ink supply system and a three-dimensional bioprinting method for manufacturing artificial blood vessels. The bioink supply system is designed to continuously supply an active bioink to a syringe of a bioprinter during 3D bioprinting. This system includes a hydrogel storage part, a cell storage part, a mixing part, a sensor part, and a controller. The mixing part is responsible for preparing the bioink by mixing hydrogel and cell solutions, ensuring a constant level of bioink in the syringe. This innovation allows for the continuous printing of large-scale biotissues and organ-on-a-chip devices.
The second patent focuses on a 3D printing system for manufacturing artificial blood vessels. This system involves creating a cylindrical support with a hollow 3D porous structure using a thermoplastic polymer. A hydrogel is then discharged into the support, maintaining its structure and shape throughout the printing process. This method enables the production of artificial blood vessels with a hollow multilayered structure, which is crucial for various medical applications.
Career Highlights
Geun Seon Ahn is currently associated with T&R Biofab Co., Ltd., where he continues to innovate in the field of bioprinting. His work is characterized by a strong emphasis on practical applications that can significantly impact healthcare and medical technology.
Collaborations
Ahn collaborates with notable colleagues, including Min Kyung Kim and Kyung Hyun Min, who contribute to the research and development efforts at T&R Biofab Co., Ltd. Their combined expertise enhances the potential for groundbreaking advancements in bioprinting technology.
Conclusion
Geun Seon Ahn's contributions to bioprinting technology are noteworthy and reflect his commitment to advancing medical science. His innovative patents and collaborative efforts position him as a key figure